Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Jiangsu Hengrui Medicine Co. Ltd.
DescriptionFixed-dose combination of 100 mg SP2086 and 20 mg simvastatin
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26) ; HMG-CoA reductase
Mechanism of ActionHMG-CoA reductase inhibitor; Dipeptidyl peptidase (DPP) inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today